Movement Alert|Intel Rises 4.45% in Regular Trading, $20 Billion Stock Offering Massively Oversubscribed Boosting Market Confidence

Market Focus
Aug 12

On August 12, Intel rose 4.45% in regular trading, trading at $101.7/share, with turnover of $1.316 billion.

On the news front, Intel completed pricing of its upsized $20 billion public stock offering, issuing approximately 210.5 million shares at $95 per share. Subscription demand reportedly exceeded $100 billion, with about 33% of investor orders not receiving allocation, signaling strong institutional conviction in the company's long-term prospects. The offering was initially planned at $15 billion before being upsized due to overwhelming demand.

The prior selloff driven by dilution concerns quickly reversed after the offering was finalized, with market focus shifting to the oversubscription signal. Investor Dan Niles suggested the large-scale fundraise may indicate Intel is close to signing a major foundry customer. Additionally, CEO Lip-Bu Tan disclosed the company is exploring next-generation memory architecture while maintaining its vertically integrated strategy across products, advanced packaging, and foundry services. UBS adjusted its price target from $112 down from $121 while maintaining a Neutral rating; the analyst consensus average target stands at $121.24 with an overweight rating.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10